Short answer
Humana (HUM) filed its Q2 2026 10-Q quarterly report on Jul 29, 2026 for the quarter ended Jun 30, 2026.
Humana Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Total revenue $40.9B, up 26.2% YoY from $32.4B, driven by Insurance premiums
- Operating margin 3.3% vs 3.4% YoY, with benefit ratio 91.1% vs 89.7%
- Insurance best-performing segment: revenue $39.0B, up 26.2%; operating income $820M vs $766M
- Stand-alone PDP strongest product: revenue $3.0B, up 74.0% YoY; state-based contracts weakest, up 1.2%
- Cash deployment: $908M MaxHealth acquisition; $56M value-creation charges, with additional charges expected
- Headwinds: BY 2026 Star Ratings, higher new-member benefit ratios, regulatory changes, and anticipated lower favorable claims development
Risk Factors
- No new risk factors; Humana reported no changes from the 2025 Form 10-K
- Regulatory and compliance risks remain those disclosed in the 2025 Form 10-K
- Operational, competitive, and market risks remain unchanged from the 2025 Form 10-K
- Financial risks remain unchanged from the 2025 Form 10-K
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Humana quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.